FAM157A expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.821400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.753400E-01
Normal-vs-Stage2
4.197600E-01
Normal-vs-Stage3
3.615800E-01
Normal-vs-Stage4
6.435200E-01
Stage1-vs-Stage2
1.225180E-01
Stage1-vs-Stage3
8.872300E-02
Stage1-vs-Stage4
8.866600E-01
Stage2-vs-Stage3
2.814000E-01
Stage2-vs-Stage4
3.620800E-01
Stage3-vs-Stage4
1.983440E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.064200E-01
Normal-vs-AfricanAmerican
9.654200E-01
Normal-vs-Asian
4.981200E-01
Caucasian-vs-AfricanAmerican
7.756000E-01
Caucasian-vs-Asian
1.368470E-02
AfricanAmerican-vs-Asian
4.176600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.497600E-01
Normal-vs-Female
6.092600E-01
Male-vs-Female
8.504800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.302200E-01
Normal-vs-Age(41-60Yrs)
6.400600E-01
Normal-vs-Age(61-80Yrs)
5.123400E-01
Normal-vs-Age(81-100Yrs)
6.219000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
1.585030E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.450300E-02
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.458400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
7.517200E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
6.545600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.918800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
6.927200E-01
Normal-vs-Daily Drinker
6.499600E-01
Normal-vs-Weekly Drinker
3.146200E-01
Normal-vs-Occasional Drinker
7.100200E-01
Normal-vs-Social Drinker
8.177800E-01
Non Drinker-vs-Daily Drinker
7.977800E-01
Non Drinker-vs-Weekly Drinker
4.660000E-01
Non Drinker-vs-Occasional Drinker
7.220600E-01
Non Drinker-vs-Social Drinker
2.187600E-01
Daily Drinker-vs-Weekly Drinker
4.882000E-01
Daily Drinker-vs-Occasional Drinker
9.124200E-01
Daily Drinker-vs-Social Drinker
5.364000E-01
Weekly Drinker-vs-Occasional Drinker
4.469200E-01
Weekly Drinker-vs-Social Drinker
1.025560E-01
Occasional Drinker-vs-Social Drinker
6.421000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
N/A
Normal-vs-Grade 2
N/A
Normal-vs-Grade 3
N/A
Normal-vs-Grade 4
N/A
Grade 1-vs-Grade 2
6.554400E-01
Grade 1-vs-Grade 3
9.796400E-01
Grade 1-vs-Grade 4
N/A
Grade 2-vs-Grade 3
5.559000E-01
Grade 2-vs-Grade 4
N/A
Grade 3-vs-Grade 4
N/A
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.903800E-01
Normal-vs-NonDiabetic
5.900400E-01
Diabetic-vs-NonDiabetic
5.065600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
9.272600E-01
Normal-vs-NoPancreatitis
3.818200E-01
Pancreatitis-vs-NoPancreatitis
2.592000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
8.405000E-01
Normal-vs-N1
4.441000E-01
N0-vs-N1
2.549400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
8.593200E-01
Normal-vs-TP53-NonMutant
8.627000E-01
TP53-Mutant-vs-TP53-NonMutant
9.919600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
